000 01279 a2200361 4500
005 20250515074421.0
264 0 _c20071018
008 200710s 0 0 eng d
022 _a1469-493X
024 7 _a10.1002/14651858.CD000155.pub2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHughes, E
245 0 0 _aOvulation suppression for endometriosis.
_h[electronic resource]
260 _bThe Cochrane database of systematic reviews
_cJul 2007
300 _aCD000155 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Systematic Review
650 0 4 _aDanazol
_xtherapeutic use
650 0 4 _aEndometriosis
_xcomplications
650 0 4 _aEstrogen Antagonists
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aFertility Agents, Female
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aInfertility, Female
_xdrug therapy
650 0 4 _aOvulation
_xdrug effects
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aBrown, J
700 1 _aCollins, J J
700 1 _aFarquhar, C
700 1 _aFedorkow, D M
700 1 _aVandekerckhove, P
773 0 _tThe Cochrane database of systematic reviews
_gno. 3
_gp. CD000155
856 4 0 _uhttps://doi.org/10.1002/14651858.CD000155.pub2
_zAvailable from publisher's website
999 _c17171096
_d17171096